Cited by 381Alzheimer's disease research and treatmentsProtein purification and stabilityDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths

Open access

Snyder, S.W., Ladror, U.S., Wade, W.S., Wang, G.T., Barrett, L.W., Matayoshi, E.D., Huffaker, H.J., Krafft, G.A., Holzman, T.F.·1994·Biophysical Journal

DOI 10.1016/s0006-3495(94)80591-0PMC PMC1225478

Open this paper in CoChat — free account

Abstract

One of the clinical manifestations of Alzheimer's disease is the deposition of the 39-43 residue amyloid-beta (A beta) peptide in aggregated fibrils in senile plaques. Characterization of the aggregation behavior of A beta is one of the critical issues in understanding the role of A beta in the disease process. Using solution hydrodynamics, A beta was observed to form three types of species in phosphate-buffered saline: insoluble aggregates with sedimentation coefficients of approximately 50,000 S and molecular masses of approximately 10(9) Da, "soluble aggregates" with sedimentation coefficients of approximately 30 S and masses of approximately 10(6) Da, and monomer. When starting from monomer, the aggregation kinetics of A beta 1-40 (A beta 40) and A beta 1-42 (A beta 42), alone and in combination, reveal large differences in the tendency of these peptides to aggregate as a function of pH and other solution conditions. At pH 4.1 and 7.0-7.4, aggregation is significantly slower than at pH 5 and 6. Under all conditions, aggregation of the longer A beta 42 was more rapid than A beta 40. Oxidation of Met-35 to the sulfoxide in A beta 40 enhances the aggregation rate over that of the nonoxidized peptide. Aggregation was found to be dependent upon temperature and to be strongly dependent on peptide concentration and ionic strength, indicating that aggregation is driven by a hydrophobic effect. When A beta 40 and A beta 42 are mixed together, A beta 40 retards the aggregation of A beta 42 in a concentration-dependent manner. Shorter fragments have a decreasing ability to interfere with A beta 42 aggregation. Conversely, the rate of aggregation of A beta 40 can be significantly enhanced by seeding slow aggregating solutions with preformed aggregates of A beta 42. Taken together, the inhibition of A beta 42 aggregation by A beta 40, the seeding of A beta 40 aggregation by A beta 42 aggregates, and the chemical oxidation of A beta 40 suggest that the relative abundance and rates of production of different-length A beta and its exposure to radical damage may be factors in the accumulation of A beta in plaques in vivo.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/s0006-3495(94)80591-0

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease
Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Amyloid Deposits and Amyloidosis
Glenner, G. G. (1980) · New England Journal of Medicine · doi:10.1056/nejm198006053022305 · Cited by 1,780
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91209-9 · Cited by 1,693
An Increased Percentage of Long Amyloid β Protein Secreted by Familial Amyloid β Protein Precursor (βApp 717 ) Mutants
Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., & Younkin, S. G. (1994) · Science · doi:10.1126/science.8191290 · Cited by 1,471

Show all 55 references

Research works printed but not linked: 4

Gorevic, P. D., P. C. Munoz, T. T. Casey, C. R. Diraimondo, W. J. Stone, F. C. Prelli, M K Rodrigues, K D. Poulk, and B. Franikone. 1986. Ten to fourt residue pepqides of Alzheimer's disease protein are sufficient for amyloid fibril formaton and its characteristic x-ray dffraction pattern. Proc. Natl Acad Sci USA. 83:7908-7912.
Holzman, T. F., and S. W. Snyder. 1994. Applicatons of analytical ultra- centrugation i sucture-bsed drug design. In Modern Analytical Ul- tracentifugation: Acquisition and Interpretation of Data for Biological and Synthetic Polymer Systems. T. M. Schuster, T. M. Laue, editors. Boston, Birkhauser Division, Springer-Verlag.
Kirschner, D. A, C. R. Abraham, and D. J. Selkoe. 1986. X-ray diffractio from intraneuronal paired helical filaments and extraneuronal amyloid fibminAlzheimer disease indicates cross-beta conformation. Proc. NatiL Acad ScL U.S.A 86:503-507.
Krafft, G. A. 1993. Perspectives on amyloid and Alzheimer's disease: a critical review. Annu. Rep. Mled Chem 28:49-58.

Sorted by citations

Items 301–380 of 380

Incubation of Amyloidogenic Peptides in Reverse Micelles Allow Active Control of Oligomer Size and Study of Protein–Protein Interactions
Chang, H., Yang, C., & Chan, J. C. C. (2024) · ChemMedChem · doi:10.1002/cmdc.202400310 · Cited by 7
DMSO affects Aβ 1–40 's conformation and interactions with aggregation inhibitors as revealed by NMR
Laurents, D. V., Pantoja‐Uceda, D., López, L. C., Carrodeguas, J. A., Mompeán, M., Jiménez, M. A., & Sancho, J. (2015) · RSC Advances · doi:10.1039/c5ra12100k · Cited by 7
Endogenous mouse huntingtin is highly abundant in cranial nerve nuclei, co-aggregates to Abeta plaques and is induced in reactive astrocytes in a transgenic mouse model of Alzheimer’s disease
Hartlage‐Rübsamen, M., Ratz, V., Zeitschel, U., Finzel, L., Machner, L., Köppen, J., Schulze, A., Demuth, H., von Hörsten, S., Höfling, C., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0726-2 · Cited by 7
4-Chlorobutanol induces unusual reversible and irreversible thermal unfolding of ribonuclease A: thermodynamic, kinetic, and conformational characterization
Mehta, R., Kundu, A., & Kishore, N. (2004) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2003.11.001 · Cited by 7
Homocysteine thiolactone and H2O2 induce amino acid modifications and alter the fibrillation propensity of the Aβ25–35 peptide
Bag, S., Konar, M., Roy, P., DasGupta, S., & Dasgupta, S. (2023) · FEBS Letters · doi:10.1002/1873-3468.14583 · Cited by 6
Aβ∗56 is a stable oligomer that impairs memory function in mice
Liu, P., Lapcinski, I. P., Hlynialuk, C. J. W., Steuer, E. L., Loude, T. J., Shapiro, S. L., Kemper, L. J., & Ashe, K. H. (2024) · iScience · doi:10.1016/j.isci.2024.109239 · Cited by 6
Beneficial Role of Curcumin in Preventing the Aggregation of the Amyloid-β Peptide in Alzheimer’s Disease
Banerjee, R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815461-8.00019-0 · Cited by 7
Exploring Heparan Sulfate Proteoglycans as Mediators of Human Mesenchymal Stem Cell Neurogenesis
Petersen, S. I., Okolicsanyi, R. K., & Haupt, L. M. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01463-8 · Cited by 8
The Wnt/β-catenin signaling pathway affects the distribution of cytoskeletal proteins in Aβ treated PC12 cells
Tian, Z.-F., Zhang, X., Zhao, Z., Zhang, F.-H., & Deng, T.-X. (2019) · Journal of Integrative Neuroscience · doi:10.31083/j.jin.2019.03.168 · Cited by 6
The Affinity of Some Lewis Bases for Hexafluoroisopropanol as a Reference Lewis Acid: An ITC/DFT Study
Milovanović, M. R., Dherbassy, Q., Wencel‐Delord, J., Colobert, F., Zarić, S. D., & Djukic, J. (2020) · ChemPhysChem · doi:10.1002/cphc.202000560 · Cited by 6
Ultrasensitive Assays Detect Different Conformations of Plasma β Amyloids
Li, C.-Y., Fan, L., Lin, C., Hu, C., & Chiu, M. (2025) · ACS Omega · doi:10.1021/acsomega.4c10879 · Cited by 5
Effects of hydrocarbon chain on the vesicle size distribution, kinetics of average size, bending modulus, and elastic modulus of lipid membranes
Hossain, M. I., Karal, M. A. S., Kamruzzaman, M., Syed, I. M., Hasan, S., & Ahamed, M. K. (2022) · The European Physical Journal E · doi:10.1140/epje/s10189-022-00209-y · Cited by 5
Identification of post-translational modifications of Aβ peptide in platelet membranes from patients with cerebral amyloid angiopathy
Song, L., Xue, R., Ge, P., Li, M., Wang, L. Y., Zheng, F., Zhao, L., Wang, Z., Wang, Z., Wang, Q., et al. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.08.3269 · Cited by 5
Aggregation and conformational studies on a pentapeptide derivative
Sambasivam, D., Liu, C. W., Jayaraman, M., Malar, E. J. P., & Rajadas, J. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.07.015 · Cited by 5
Amyloid precursor protein and tau transgenic models of Alzheimer‘s disease: insights from the past and directions for the future
Sahara, N., & Lewis, J. M. (2010) · Future Neurology · doi:10.2217/fnl.10.10 · Cited by 5
Alzheimer’s β-Amyloid Peptide and Free Radical Oxidative Stress
Butterfield, D. A. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46806-9_25 · Cited by 5
Alzheimer's disease imaging biomarkers using small-angle x-ray scattering
Choi, M., Alam, N., Dahal, E., Ghammraoui, B., & Badano, A. G. (2016) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2217408 · Cited by 4
Obstacles to translating the promise of nanoparticles into viable amyloid disease therapeutics
van der Munnik, N. P., Moss, M. A., & Uline, M. J. (2019) · Physical Biology · doi:10.1088/1478-3975/aafc66 · Cited by 4
The Rat in Neuroscience Research
El-Ayache, N. C., & Galligan, J. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814338-4.00028-3 · Cited by 4
A mass spectrometric approach to study the interaction of amyloid β peptides with human α-2-macroglobulin
Protasov, A. V., Mirgorodskaya, O. A., Kozmin, Y., & Gobom, J. (2021) · Biochimie · doi:10.1016/j.biochi.2021.08.008 · Cited by 4
New Hypothesis Insight of Structural Properties on Four Tau Peptide Fragments in Alzheimer's Disease: Origin from the Histidine Behaviors
Sun, Y., Li, C., Wang, J., & Shi, H. (2023) · Chemistry - A European Journal · doi:10.1002/chem.202300868 · Cited by 4
β-amyloid-Derived Free Radical Oxidation
Butterfield, D. A., Hensley, K., Hall, N. C., Ramachandran, S., Howard, B. J., Cole, P. S., Yatin, S. M., LaFontaine, M., Harris‐White, M. E., Aksenova, M. V., et al. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_9 · Cited by 4
Understanding and Ameliorating the TTR Amyloidoses
Johnson, S. M., Wiseman, R. L., Paulsson, J. F., Choi, S., Powers, E. T., Buxbaum, J. N., & Kelly, J. W. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch45 · Cited by 4
Chapter 3. β-Amyloid as a Target for Alzheimer's Disease Therapy
Augelli‐Szafran, C. E., Walker, L. C., & LeVine, H. (1999) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)60565-5 · Cited by 4
Protein folding, cellular stress and cancer
Aranda‐Anzaldo, A., Dent, M. A. R., Segura-Anaya, E., & Martínez-Gómez, A. (2024) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2024.07.001 · Cited by 4
The effect of histidine behaviors on the structural properties of Aβ(1–42) peptide in protonation stage one, two, and three
Sun, Y., Li, C., Wang, J., & Shi, H. (2023) · Physical Chemistry Chemical Physics · doi:10.1039/d3cp01405c · Cited by 3
Alzheimer's Disease Protein Targets: Comprehensive Review and Future Directions
Kumar, B. S. H., Dinesh, B. G. H., Shajan, S. R. O., Sadashivappa, N. M., Ammunje, D. N., Kunjiappan, S., Theivendren, P., & Pavadai, P. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128334916241006195142 · Cited by 3
Purification of recombinant Aβ(1‐42) and pGlu‐Aβ(3‐42) using preparative SDS‐PAGE
Spahn, C., Wermann, M., Eichentopf, R., Hause, G., Schlenzig, D., & Schilling, S. (2017) · Electrophoresis · doi:10.1002/elps.201700154 · Cited by 3
Discrete conformational changes as regulators of the hydrolytic properties of beta‐amyloid (1–40)
Brzyska, M., Trześniewska, K., Gers, T., & Elbaum, D. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05549.x · Cited by 3
Reduction of the C191-C220 disulfide of α-chymotrypsinogen A reduces nucleation barriers for aggregation
Weiss, W. F., Zhang, A., Ivanova, M. I., Şahin, E., Jordan, J. L., Fernández, E., & Roberts, C. J. (2013) · Biophysical Chemistry · doi:10.1016/j.bpc.2013.11.005 · Cited by 3
Prion-Like Propagation in Neurodegenerative Diseases
Peelaerts, W., Baekelandt, V., & Brundin, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00008-0 · Cited by 3
Electrochemical Monitoring of Reduction and Binding of Iron Amyloid-β Complexes at Boron-Doped Diamond Electrode
Zhang, G., Huo, Z., Zhou, Y., Zhu, X., Wang, H., Liang, Y. L., & Xu, M. (2012) · International Journal of Electrochemical Science · doi:10.1016/s1452-3981(23)16255-9 · Cited by 3
Apolipoprotein E Oxidation and Functional Consequences
Leininger‐Muller, B., Jolivalt, C. G., Pillot, T., Lagrange, P., Livertoux, M.-H., Grassiot, M.-C., Minn, A., & Siest, G. (1996) · Springer eBooks · doi:10.1007/978-3-642-80109-9_14 · Cited by 3
Role of Post‐translational Chemical Modifications in Amyloid Fibril Formation
Nilsson, M. R. (2005) · doi:10.1002/9783527619344.ch5 · Cited by 3
Solid-phase synthesis and purification of β-amyloid (1-42)
Sidorova, M. V., Molokoedov, A. S., Ovchinnikov, M. V., Bespalova, Z. D., Kudryavtseva, E. V., Rubina, A. Y., Bushuev, V. N., Schmidt, M., & Klose, A. (1996) · Mendeleev Communications · doi:10.1070/mc1996v006n06abeh000738 · Cited by 2
Investigation of Cytotoxicity and Ion Flux Induced by Various Aggregation States of Amyloid-Beta Peptides.
Prangkio, P. (2011) · Deep Blue (University of Michigan) · Cited by 2
Amyloid Fibril Formation on Neuronal Cells in the Coexistence of Aβ40 and Aβ42
Kawaguchi, M., Kawano, K., Taniguchi, A., Tanaka, A., & Matsuzaki, K. (2024) · ChemBioChem · doi:10.1002/cbic.202400603 · Cited by 1
The Molecular Mechanism of Amyloidosis in Alzheimer’s Disease
Zagorski, M. G. (1999) · CRC Press eBooks · doi:10.1201/9780203909607.ch14 · Cited by 1
DOCKING STUDIES OF PLANT POLYPHENOLS WITH AΒ FRAGMENTS SUGGESTS DETERMINANTS THAT ENABLE DESIGN OF INHIBITORS TOWARDS PREVENTING AGGREGATION EVENTS DURING ALZHEIMER’S
Shruthila, N., Narayan, P., Kumar, D. J., & Nagendra, H. G. (2013) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2013.050407 · Cited by 1
Post‐translational Chemical Modifications in Amyloid Fibril Formation
Nilsson, M. R. (2008) · Protein Science Encyclopedia · doi:10.1002/9783527610754.md13 · Cited by 1
Chemistry and Biology of Amyloid Inhibition
Findeis, M. A. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch41 · Cited by 1
Surprising toxicity and assembly behavior of amyloid beta-protein oxidized to sulfone.
Maiti, P., Piacentini, R., Ripoli, C., Grassi, C., & Bitan, G. (2011) · Cited by 1
Insight into Cross-Amyloid Interactions and Morphologies: Molecular Dynamics Simulations of Model Peptide Fragments of Amyloid-β (Aβ 16-22 ) and Islet Amyloid Polypeptide (IAPP 20-29 )Preprint
Cramer, N. A., Kawecki, G., King, K. M., Bevan, D. R., & Brown, A. M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.26.461861 · Cited by 1
Etude des effets des peptides amyloïdes : du fonctionnement de la synapse aux modifications du cytosquelette dans l'apoptose neuronale.
Arbez, N. (2005) · HAL · Cited by 1
Sedimentation Velocity Centrifugation
Holzman, T. F. (2002) · Encyclopedia of Molecular Biology · doi:10.1002/047120918x.emb1390
Self-citation
Tianeptine induces GluA1 phosphorylation and subsequent alteration of the firing properties of CA1 neurons
Barkóczi, B. (2013) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.1769
Cytotoxic properties of amyloidogenic L68Q cystatin C. A search for therapeutic agents
Ingólfsdóttir, I. E. (2013)
Role of the 39-kDa receptor-associated protein (RAP) in Alzheimer's disease
Hoang, T. (2012) · UTAS Research Repository · doi:10.25959/23206328
Effects of amyloidogenic peptides on the phosphorylation state of the tau-protein and on the expression of the alpha7 subunit of the nicotinic acetylcholine receptor in vitro
Lain, E. (2004) · Kölner Universitäts PublikationsServer (Universität zu Köln)
DeNoPa Kassel: Die prospektive Langzeit-Follow-up-Studie zu Biomarkern und nicht-motorischen Symptomen bei Morbus Parkinson - Pilotstudie baseline
Werner, S. (2012) · doi:10.53846/goediss-1646
Dynamic Imaging by Fluorescence Correlation Spectroscopy Identifies Diverse Populations of Polyglutamine Oligomers
Beam, M., Silva, M. C., & Morimoto, R. I. (2012)
Dynamics of amyloid plaque formation in Alzheimer’s Disease
McCarter, J. F. (2014) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.17434
Tolfenamic Acid Interrupts the De Novo Synthesis of Plaque-Forming Amyloid Beta Peptides: Implications for Alzheimers Disease
Adwan, L. I. (2008) · doi:10.23860/thesis-adwan-lina-2008
Alpha-synuclein expression influences the processing of the amyloid precursor protein
Hall‐Roberts, H. (2016) · The University of Bath Online Publications Store (The University of Bath)
MOLECULAR SIMULATION BETWEEN AMYLOID BETA (1-42), A PEPTIDE ASSOCIATED WITH ALZHEIMER DISEASE, AND ZINC(II) ION
Ghani, N. S. A. (2017) · Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia) · doi:10.13140/rg.2.2.17627.98088
Amyloid-beta Causes Autophagy Dysfunction by Inhibiting Protein Prenylation
Smith, K. T. (2016) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3vx06f9k
BEHAVIORAL AND MOLECULAR IMPACT OF CHRONIC PSYCHOSOCIAL STRESS IN A NOVEL PRE-CLINICAL MODEL OF ALZHEIMER'S DISEASE
Alkadhi, K. A. (2015) · doi:10.13140/rg.2.2.19187.27687
Cysteine in Alzheimer's Disease
Ingale, S. P., Patil, R., & Upaganlawar, A. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-1317-0.ch013
Endocrine System
(2010) · CRC Press eBooks · doi:10.1201/ebk1439813423-c4
Aβ*56 is a Stable Oligomer That Correlates with Age-Related Memory Loss in Tg2576 MicePreprint
Liu, P., Lapcinski, I. P., Shapiro, S. L., Kemper, L. J., & Ashe, K. H. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.20.533414
Key Factors Controlling Fibril Formation of Proteins
Thu, T. T. M., Phung, H. N. T., Co, N. T., Kloczkowski, A., & Li, M. S. (2024) · Acta Physica Polonica A · doi:10.12693/aphyspola.145.s21
The influence of neprilysin on the pathogenesis of sporadic Alzheimer’s disease
Hornung, K. A. (2024) · doi:10.53846/goediss-10498
Neuroprotective and nootropic effects of a standardised Siddha polyherbal formulation, Bhiramiyadhi bhavanai choornam, against β-amyloid-Induced neurodegeneration
Bhosale, S. S., Chakor, R., Lohidasan, S., Sivakkumar, S., & Sathiyanarayanan, A. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120850
Etude de la dynamique de tau dans le compartiment synaptique dans un contexte physiologique et pathologique exemple de la maladie d'Alzheimer
Frandemiche, M. (2013) · theses.fr (ABES) · doi:10.70675/260ed9c4zd958z47e0za418z0f324a1b102b
Additional file 2 of Heparanase overexpression impedes perivascular clearance of amyloid-β from murine brain: relevance to Alzheimer’s disease
Zhang, X., O’Callaghan, P., Li, H., Tan, Y., Zhang, G., Barash, U., Wang, X., Lannfelt, L., Vlodavsky, I., Lindahl, U., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14570351
Additional file 3 of Heparanase overexpression impedes perivascular clearance of amyloid-β from murine brain: relevance to Alzheimer’s disease
Zhang, X., O’Callaghan, P., Li, H., Tan, Y., Zhang, G., Barash, U., Wang, X., Lannfelt, L., Vlodavsky, I., Lindahl, U., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14570354
Additional file 4 of Heparanase overexpression impedes perivascular clearance of amyloid-β from murine brain: relevance to Alzheimer’s disease
Zhang, X., O’Callaghan, P., Li, H., Tan, Y., Zhang, G., Barash, U., Wang, X., Lannfelt, L., Vlodavsky, I., Lindahl, U., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14570357
Additional file 6 of Heparanase overexpression impedes perivascular clearance of amyloid-β from murine brain: relevance to Alzheimer’s disease
Zhang, X., O’Callaghan, P., Li, H., Tan, Y., Zhang, G., Barash, U., Wang, X., Lannfelt, L., Vlodavsky, I., Lindahl, U., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14570348
Additional file 1 of Heparanase overexpression impedes perivascular clearance of amyloid-β from murine brain: relevance to Alzheimer’s disease
Zhang, X., O’Callaghan, P., Li, H., Tan, Y., Zhang, G., Barash, U., Wang, X., Lannfelt, L., Vlodavsky, I., Lindahl, U., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14570363
Additional file 1 of Effect of policosanol from insect wax on amyloid β-peptide-induced toxicity in a transgenic Caenorhabditis elegans model of Alzheimer’s disease
Zhang, X., Ma, C., Sun, L., He, Z., Feng, Y., Li, X., Gan, J., & Chen, X. (2021) · Figshare · doi:10.6084/m9.figshare.14344481
Additional file 5 of Heparanase overexpression impedes perivascular clearance of amyloid-β from murine brain: relevance to Alzheimer’s disease
Zhang, X., O’Callaghan, P., Li, H., Tan, Y., Zhang, G., Barash, U., Wang, X., Lannfelt, L., Vlodavsky, I., Lindahl, U., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14570360
The Proteome of Human Amyloid Beta Oligomers
Kass, B., Poschmann, G., Demir, F., Huesgen, P. F., Stühler, K., Kutzsche, J., & Willbold, D. (2026) · Biochemistry · doi:10.1021/acs.biochem.5c00597 · Cited by 1
Histidine behaviors effect on β-sheet-rich dimer formation of Tau R3 fragment: New insights on primary nucleation processes
Shi, H., Li, J., Sun, Y., Wang, L., Yan, L., & Pu, X. (2026) · Biophysical Chemistry · doi:10.1016/j.bpc.2026.107602
A Highly Sensitive Water-Soluble Donor–Acceptor Dye for Early-Stage Amyloid Aggregation Kinetics
Scattolini, G., Torres-Méndez, C. E., Valli, D., Kuska, M. I., Kaul, N., Hammarström, L., Tian, H., & Maj, M. (2026) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5c07705
Génération de cellules souches pluripotentes induites de patients Alzheimer et production d'un modèle de culture en trois dimensions de neurones pour les recherches diagnostiques et thérapeutiques de la maladie d’Alzheimer
Auboyer, L. (2018) · theses.fr (ABES) · doi:10.70675/07243ef7zb974z4ad8z97d9zd046801798b1
Taylor dispersion analysis : a powerful size-based characterization technique for monitoring the aggregation of β-amyloid peptides
Deleanu, M. (2022) · theses.fr (ABES) · doi:10.70675/ac5c66b3z37eez4081za67fz47d148570e83
Etude des mécanismes physiοpathοlοgiques de la maladie d'Alzheimer : appοrt de l'étude des variants du gène SΟRL1
Castelot, R. (2024) · theses.fr (ABES) · doi:10.70675/c2a7ce1ez8caaz4593zbb3azae8add8055b5
Revisiting the role of amyloid-β: A molecular and immunological perspective
Slama, P. S. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261484863
Beta-Amyloid Inhibition of Alpha 7 Nicotinic Acetylcholine Receptors and Factors That Potentially Influence the Aβ/nAChR Interaction
Jacobsen, C. L. (2013) · ScholarsArchive (Brigham Young University)
Proinflammatory actions of derivatives of the β amyloid precursor protein
Barger, S. W. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8350-4_8

Authors: Snyder, S. W., Ladror, U. S., Wade, W. S., Wang, G. T., Barrett, L. W., Matayoshi, E. D., Huffaker, H. J., Krafft, G. A., & Holzman, T. F.
Affiliations: Abbott (United Kingdom) (GB)
Corresponding author: Holzman, T.F.
ORCID: Snyder, S.W.
Barrett, L.W.
Venue: Biophysical Journal
Publisher: Elsevier BV
Published: 1994-09
Volume: 67
Issue: 3
Pages: 1216-1228
ISSN: 0006-3495 (ISSN-L)
DOI: 10.1016/s0006-3495(94)80591-0
PMC: PMC1225478
OpenAlex: W2024559246
Cited by: 381
References: 55
Citations by year: 2026: 4 · 2025: 2 · 2024: 17 · 2023: 5 · 2022: 9 · 2021: 20 · 2020: 8 · 2019: 12 · 2018: 9 · 2017: 18 · 2016: 13 · 2015: 9 · 2014: 10 · 2013: 18 · 2012: 17
FWCI: 7.03
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 6893 d)
Locations: Biophysical Journal (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Abbott Laboratories
National Institutes of Health (7p01ag010481-05)
National Institute on Aging (AG10481)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: amyloid-beta aggregation, Alzheimer's disease, Aβ40, amyloid-beta 42, peptide length, aggregation kinetics, hydrophobic effect, seeding, aggregation inhibition, pH dependence, ionic strength, amyloid plaques
MeSH terms: Alzheimer Disease, Amino Acid Sequence, Biophysics, Humans, Kinetics, Microscopy, Electron, Molecular Sequence Data, Polymers, Protein Conformation, Solutions, Amyloid beta-Peptides, Neurofibrillary Tangles, Macromolecular Substances, Biophysical Phenomena, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks